Tag: pharma
The endocannabinoid system targeted therapeutics market - Roots Analysis post
Roots Analysis is pleased to announce the publication of its recent study, titled, “Endocannabinoid System Targeted Therapeutics Market, 2020-2030
The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30%, claims Roots Analysis
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.
Growing at an annualized rate of over 35%, the large volume wearable injectors market
Over the years, a rise in preference for self-administrable drugs / therapies has resulted in an increasing demand for user-friendly drug delivery solutions that are not only safe and efficient, but also promote therapy adherence
The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion
Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access
The “Antibody Contract Manufacturing Market, 2020-2030” report - Roots Analysis'
Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody...
companies required expertise and infrastructure to offer contract manufacturing services for a variety of antibody-based products - Roots Analysis'
Roots Analysis has done a detailed study on Antibody Contract Manufacturing Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The antibody contract manufacturing market is estimated to be worth USD 17 billion - Roots Analysis'
The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well
The antibody contract manufacturing market is projected to reach USD 17 billion by 2030 - Roots Analysis'
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report - Roots Analysis'
The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.
The bispecific antibody therapeutics pipeline has evolved significantly over the past few years - Roots Analysis'
With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications.
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16% - Roots Analysis'
Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion - Roots Analysis'
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community
Roots Analysis'The virtual clinical trial service providers market is projected to grow at an annualized rate of ~14%- Roots Analysis'
Roots Analysis has done a detailed study on Virtual Clinical Trial Service Providers Market, 2020-2050, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The virtual clinical trial service providers market is estimated to be worth USD 12 billion in 2050- Roots Analysis'
Conventional clinical trials are fraught with inefficient patient management and data handling practices, which has prompted trial sponsors to implement digital innovation and virtual technologies across different aspects of drug development.
The gene therapy market is projected to be growing at a CAGR of 30%- Roots Analysis'
Given their potential to treat rare, inherited diseases, as well as those previously deemed incurable, the field of gene therapy has gained significant traction in the last few years
